These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 26199176

  • 21. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M.
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [Abstract] [Full Text] [Related]

  • 22. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 23. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
    Kaimakliotis HZ, Monn MF, Cary KC, Pedrosa JA, Rice K, Masterson TA, Gardner TA, Hahn NM, Foster RS, Bihrle R, Cheng L, Koch MO.
    Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
    [Abstract] [Full Text] [Related]

  • 24. Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.
    Aziz A, Lessard A, Moore K, Hovington H, Latulippe E, Larue H, Fradet Y, Lacombe L.
    BJU Int; 2011 Aug; 108(4):531-7. PubMed ID: 21166751
    [Abstract] [Full Text] [Related]

  • 25. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?
    Scosyrev E, Yao J, Messing E.
    Urology; 2009 Apr; 73(4):822-7. PubMed ID: 19193403
    [Abstract] [Full Text] [Related]

  • 26. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF.
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
    Kassouf W, Spiess PE, Siefker-Radtke A, Swanson D, Grossman HB, Kamat AM, Munsell MF, Guo CC, Czerniak BA, Dinney CP.
    Cancer; 2007 Aug 15; 110(4):764-9. PubMed ID: 17614317
    [Abstract] [Full Text] [Related]

  • 32. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
    Cohen AJ, Packiam V, Nottingham C, Steinberg G, Smith ND, Patel S.
    Urol Oncol; 2017 Jan 15; 35(1):34.e1-34.e8. PubMed ID: 27592529
    [Abstract] [Full Text] [Related]

  • 33. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.
    Urol Oncol; 2013 Nov 15; 31(8):1643-9. PubMed ID: 22591745
    [Abstract] [Full Text] [Related]

  • 34. Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.
    Dotson A, May A, Davaro F, Raza SJ, Siddiqui S, Hamilton Z.
    Int J Clin Oncol; 2019 Jun 15; 24(6):706-711. PubMed ID: 30707342
    [Abstract] [Full Text] [Related]

  • 35. Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base.
    Royce TJ, Lin CC, Gray PJ, Shipley WU, Jemal A, Efstathiou JA.
    Urol Oncol; 2018 Feb 15; 36(2):78.e1-78.e12. PubMed ID: 29162314
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP.
    J Urol; 2006 Jun 15; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [Abstract] [Full Text] [Related]

  • 40. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec 15; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.